LFS-associated hypodiploid ALL, associated with poor prognosis, exhibit TP53 loss of heterozygosity, along with alterations in IKZF2 (65%) and RAS pathway genes (9%) [80, 82]. This evidence concerns the gene TP53 and acute lymphoblastic leukemia.